Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment
- PMID: 35727290
- DOI: 10.1001/jama.2022.9846
Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical